U.S. flag

An official website of the United States government

NM_000198.4(HSD3B2):c.512G>A (p.Trp171Ter) AND 3 beta-Hydroxysteroid dehydrogenase deficiency

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Oct 12, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000012967.4

Allele description [Variation Report for NM_000198.4(HSD3B2):c.512G>A (p.Trp171Ter)]

NM_000198.4(HSD3B2):c.512G>A (p.Trp171Ter)

Gene:
HSD3B2:hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p12
Genomic location:
Preferred name:
NM_000198.4(HSD3B2):c.512G>A (p.Trp171Ter)
HGVS:
  • NC_000001.11:g.119422013G>A
  • NG_013349.1:g.12083G>A
  • NM_000198.4:c.512G>AMANE SELECT
  • NM_001166120.2:c.512G>A
  • NP_000189.1:p.Trp171Ter
  • NP_001159592.1:p.Trp171Ter
  • NC_000001.10:g.119964636G>A
Protein change:
W171*; TRP171TER
Links:
OMIM: 613890.0001; dbSNP: rs80358216
NCBI 1000 Genomes Browser:
rs80358216
Molecular consequence:
  • NM_000198.4:c.512G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001166120.2:c.512G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
3 beta-Hydroxysteroid dehydrogenase deficiency
Synonyms:
Adrenal hyperplasia 2; Adrenal hyperplasia II; 3b-hydroxysteroid dehydrogenase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008727; MeSH: C538236; MedGen: C0342471; OMIM: 201810

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000033211OMIM
no assertion criteria provided
Pathogenic
(Jul 1, 1992)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV002094666Natera, Inc.
no assertion criteria provided
Pathogenic
(Oct 12, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.

Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F.

Nat Genet. 1992 Jul;1(4):239-45.

PubMed [citation]
PMID:
1363812

3 beta-hydroxysteroid dehydrogenase deficiency. Follow-up study in a girl with pubertal bone age.

Zachmann M, Forest MG, De Peretti E.

Horm Res. 1979;11(6):292-302.

PubMed [citation]
PMID:
295036

Details of each submission

From OMIM, SCV000033211.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In classic cases of congenital adrenal hyperplasia due to 3-beta-HSD deficiency (201810) in 2 related families from the same village in eastern Switzerland, Rheaume et al. (1992) identified a G-to-A transition in exon 4 of both alleles, converting codon 171 (TGG) encoding trp into a TAG-stop codon (W171X). Mutation was predicted to result in a truncated protein of 169 amino acids (excluding the first met) instead of the normal 371 amino acids of the type II 3-beta-HSD protein. One of these families, extensively described by Zachmann et al. (1979), had severe salt-wasting. There was no virilization in the proposita. Her older brother died at the age of 4 weeks with clinical signs of a salt-losing crisis. He was incompletely masculinized and was found to have marked enlargement of the adrenals at autopsy. At puberty the proposita showed lack of spontaneous breast development and absence of a rise in serum estradiol following administration of human menopausal gonadotropin, thus suggesting that the defect was also present in the ovaries.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002094666.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024